Agent Orange is usually the first thing veterans with prostate cancer ask about. Indeed, way back in 1998, Malecare was an early advocate for men exposed to Agent Orange. Military veterans as well as Vietnamese, Cambodian and Laotian civilians were exposed to Agent Orange, and many of those who are men are now diagnosed, [...]
Prostate cancer patients struggle to ask all of their questions. Men often leave their doctor's offices with one or more unanswered question...."I forgot to ask." Even with lists of questions written out in advance, patients skip over one or more questions or simply fail to give voice to things that trouble them the [...]
Erleada (apalutamide) has just received FDA approval as a drug for treating men with non-metastatic castration-resistant prostate cancer. The proper pronunciation is Er ( Errr), (Like Her without the h) ) (lee) (long E) da. Now, repeat after me, "Erleada!" It's a pill that you take - I believe - four times a [...]
Non-Metastatic Castrate Resistant Prostate Cancer (nmCRPC) usually leads to metastatic prostate cancer and death. There are no approved treatments for nmCRPC. Apalutamide is a taken-by-mouth androgen receptor inhibitor with antitumor activity in CRPC. There's a much talked and written about clinical trial called, SPARTAN, that investigated how well Apalutamide works on maintaining metastasis-free survival (MFS) [...]
Non-metastatic Castrate Resistant prostate cancer patients take note. The Phase 3 PROSPER trial in patients with non-metastatic (M0) Castration-Resistant Prostate Cancer (CRPC) showed that the use of XTANDI® (enzalutamide) plus androgen deprivation therapy (ADT) significantly reduced the risk of developing metastases or death by 71 percent compared to ADT alone. It will be a [...]
Metastatic Prostate Cancer suffers have good news. Xofigo, also known as Radium-223 (Ra-223), is a treatment for patients with castration-resistant prostate cancer (CRPC) and symptomatic (you can feel them) bone metastases (mets). Early results of an international, open-label, phase 1/2 study (NCT01934790) showed that re-treating pts with Ra-223 was well tolerated with favorable effects on [...]
Anger hurts prostate cancer treatment. I feel angry and I'm not going to take my pills or show up for IMRT session. The thing about prostate cancer is that you’re not told what to do every step of the way or how to do it. Nothing is planned out for you, you just [...]
Five Estate Planning Documents to Have When You’re Battling an Illness Whether you’re young, old, healthy, or ill, estate planning should be a top priority. However, if you’re faced with a prostate cancer or have received some other unfavorable medical diagnosis, it’s especially critical that your legal affairs are in order and up to [...]
In the twenty years since I led Malecare’s first prostate cancer support group, this is the first time I have written an annual letter. Through the upturns and downturns, Malecare has always been a voice of optimism and powerful advocate for men diagnosed with prostate cancer. As we enter 2018, we are [...]
Men with Prostate Cancer May Not Know All Of Their Treatment Options and Risks by Brian Miles, MD Urology Houston Methodist Urology Associates Professor of Urology, Institute for Academic Medicine Houston Methodist - Weill Cornell Medical College According to a September 2017 study by BJU International, men who have been diagnosed with localized prostate [...]